Skip to main content

ASND · Ascendis Pharma A/S · Analyst Estimates

Track ASND — free
$227.83 -0.24 (-0.11%) At close · Sep 30
Market Cap
$15.03B
Shares
65.78M
Volume · Sep 30 926.23K Avg daily vol (3M) 641.12K

Analyst Estimates

Compare analyst forecasts for Ascendis Pharma A/S across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-28 21:28 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
3.61
12.7916
18.69
—
11.337
11.73075
12.7704
12.0232
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
1
1
0
Revenue
EUR
Publication date not stated
1328051000
1370542190
1509100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
6.26
9.6162
16.16
—
8.15875
9.28525
9.67
9.156
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
1
1
0
Revenue
EUR
Publication date not stated
1890253000
2013303390
2302000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
0.64
0.93667
1.09
—
0.95
1.31667
0.95
1.195
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
2
2
0
0
Revenue
EUR
Publication date not stated
352403000
365231570
376000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
0.61
1.15667
1.51
—
1.17667
1.59333
1.17667
1.7525
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
2
2
0
0
Revenue
EUR
Publication date not stated
389762000
413113530
450300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —
Key facts CIK 1612042 CUSIP K08588103 13F (30d) 8 filings 8 filers Visit website Investor relations